000			02227 a2200541 4500
005			20250515164713.0
264		0	_c20090818
008			200908s 0 0 eng d
022			_a1530-6860
024	7		_a10.1096/fj.09-130542 _2doi
040			_aNLM _beng _cNLM
100	1		_aIssuree, Priya D A
245	0	0	_aResveratrol attenuates C5a-induced inflammatory responses in vitro and in vivo by inhibiting phospholipase D and sphingosine kinase activities. _h[electronic resource]
260			_bFASEB journal : official publication of the Federation of American Societies for Experimental Biology _cAug 2009
300			_a2412-24 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAnti-Inflammatory Agents, Non-Steroidal _xpharmacology
650	0	4	_aBiological Transport, Active _xdrug effects
650	0	4	_aCell Degranulation _xdrug effects
650	0	4	_aCell Membrane _xdrug effects
650	0	4	_aChemokines _xmetabolism
650	0	4	_aChemotaxis, Leukocyte _xdrug effects
650	0	4	_aComplement C5a _xadministration & dosage
650	0	4	_aCytokines _xmetabolism
650	0	4	_aDisease Models, Animal
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aExtracellular Signal-Regulated MAP Kinases _xmetabolism
650	0	4	_aHumans
650	0	4	_aIn Vitro Techniques
650	0	4	_aInflammation _xenzymology
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aNF-kappa B _xmetabolism
650	0	4	_aNeutrophils _xdrug effects
650	0	4	_aPeritonitis _xetiology
650	0	4	_aPhospholipase D _xantagonists & inhibitors
650	0	4	_aPhosphotransferases (Alcohol Group Acceptor) _xantagonists & inhibitors
650	0	4	_aRespiratory Burst _xdrug effects
650	0	4	_aResveratrol
650	0	4	_aStilbenes _xadministration & dosage
700	1		_aPushparaj, Peter N
700	1		_aPervaiz, Shazib
700	1		_aMelendez, Alirio J
773	0		_tFASEB journal : official publication of the Federation of American Societies for Experimental Biology _gvol. 23 _gno. 8 _gp. 2412-24
856	4	0	_uhttps://doi.org/10.1096/fj.09-130542 _zAvailable from publisher's website
999			_c18781505 _d18781505